PL365872A1 - Sposób wytwarzania stałej doustnej postaci dawkowania zawierającej metforminę i gliburyd, stała doustna postać dawkowania zawierająca metforminę i gliburyd oraz jej zastosowanie do wytwarzania leku - Google Patents

Sposób wytwarzania stałej doustnej postaci dawkowania zawierającej metforminę i gliburyd, stała doustna postać dawkowania zawierająca metforminę i gliburyd oraz jej zastosowanie do wytwarzania leku

Info

Publication number
PL365872A1
PL365872A1 PL36587204A PL36587204A PL365872A1 PL 365872 A1 PL365872 A1 PL 365872A1 PL 36587204 A PL36587204 A PL 36587204A PL 36587204 A PL36587204 A PL 36587204A PL 365872 A1 PL365872 A1 PL 365872A1
Authority
PL
Poland
Prior art keywords
gliburid
metformine
oral dosage
dosage containing
constant oral
Prior art date
Application number
PL36587204A
Other languages
English (en)
Inventor
Suresh Kumar Gidwani
Purushottam Sharshikant Singnurkar
Original Assignee
Usv Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Limited filed Critical Usv Limited
Publication of PL365872A1 publication Critical patent/PL365872A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL36587204A 2003-03-05 2004-03-04 Sposób wytwarzania stałej doustnej postaci dawkowania zawierającej metforminę i gliburyd, stała doustna postać dawkowania zawierająca metforminę i gliburyd oraz jej zastosowanie do wytwarzania leku PL365872A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45198903P 2003-03-05 2003-03-05

Publications (1)

Publication Number Publication Date
PL365872A1 true PL365872A1 (pl) 2004-09-06

Family

ID=32094206

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36587204A PL365872A1 (pl) 2003-03-05 2004-03-04 Sposób wytwarzania stałej doustnej postaci dawkowania zawierającej metforminę i gliburyd, stała doustna postać dawkowania zawierająca metforminę i gliburyd oraz jej zastosowanie do wytwarzania leku

Country Status (11)

Country Link
US (1) US20040175421A1 (pl)
KR (1) KR20040079325A (pl)
CN (1) CN1526383A (pl)
DE (1) DE102004010921A1 (pl)
FR (1) FR2853831A1 (pl)
GB (1) GB2399015A (pl)
IT (1) ITMI20040428A1 (pl)
PL (1) PL365872A1 (pl)
SG (1) SG129278A1 (pl)
TW (1) TW200505427A (pl)
ZA (1) ZA200401748B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540225C (en) * 2003-10-31 2012-03-06 Takeda Pharmaceutical Company Limited Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP2438911A1 (en) * 2010-10-08 2012-04-11 LEK Pharmaceuticals d.d. Pharmaceuticals compositions comprising sulphonylurea-class insulin secretagogue and polyethylene glycol castor oil
US20180008618A1 (en) * 2016-07-08 2018-01-11 Anthony I. Rozmanith Health care

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD275399B5 (de) * 1988-09-07 1994-03-31 Dresden Arzneimittel Arzneimitteltechnologisches verfahren zur herstellung einer glibenclamid-arzneiform
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
ES2206868T3 (es) * 1998-07-15 2004-05-16 Merck Sante Comprimidos que comprenden una combinacion de metformin glibenclamida.
DE19860698A1 (de) * 1998-12-30 2000-07-06 Hexal Ag Neue pharmazeutische Zusammensetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
BR0213079A (pt) * 2001-09-28 2004-11-09 Sun Pharmaceutical Ind Ltd Forma de dosagem para o tratamento da diabetes mellitus
US20060002998A1 (en) * 2002-11-15 2006-01-05 Anupam Trehan Pharmaceutical dosage forms of biguanide-sulfonylurea combinations

Also Published As

Publication number Publication date
GB2399015A (en) 2004-09-08
FR2853831A1 (fr) 2004-10-22
SG129278A1 (en) 2007-02-26
GB0404741D0 (en) 2004-04-07
KR20040079325A (ko) 2004-09-14
TW200505427A (en) 2005-02-16
US20040175421A1 (en) 2004-09-09
CN1526383A (zh) 2004-09-08
ITMI20040428A1 (it) 2004-06-05
ZA200401748B (en) 2005-09-16
DE102004010921A1 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
EP1615623A4 (en) ORAL SAFETY DOSAGE FORMS AND METHOD OF APPLICATION THEREFOR
EP1648327A4 (en) ORAL DEVICES AND METHODS OF CONTROLLED MEDICAMENT DELIVERY
EP1478345A4 (en) NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
GB0315861D0 (en) Improvements in pharmaceutical compositions for treatment of drug abuse
EP1690238A4 (en) SYSTEM AND METHOD FOR PREPARING PERSONALIZED DOSAGE FORMS OF MEDICAMENTS
ZA200508684B (en) Instrument and method for delivery of anaesthetic drug
EP1691746A4 (en) DEVICES FOR DELIVERY OF MUCOADHESIVE DRUGS AND METHODS OF MAKING AND USING SAME
IL178038A (en) Delayed-release oral dosage forms for pain management
EP1365747A4 (en) PHARMACEUTICAL PRESENTATION OF ORAL PEPTIDE ADMINISTERED AND METHOD OF PRODUCTION
PL357856A1 (pl) Farmaceutyczne granulki zawierające tamsulozynę oraz sposób ich wytwarzania
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
HUP0303800A3 (en) Pharmaceuticals and dosage forms of epothilones for oral administration
PL370554A1 (pl) Nowe związki i ich zastosowanie w medycynie, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierajace te związki
SG116507A1 (en) Pharmaceutical dosage form and method of making.
IL238491A0 (en) Oral pharmaceutical preparation for soft capsules containing vinorelbine and methods of treatment
PL2083007T3 (pl) Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
EP1654312A4 (en) PHARMACEUTICAL DOSING INHALER AND RELATED METHODS
EP1592409A4 (en) USE OF EDIBLE ACIDITY IN QUICKLY DISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORMS
PL365872A1 (pl) Sposób wytwarzania stałej doustnej postaci dawkowania zawierającej metforminę i gliburyd, stała doustna postać dawkowania zawierająca metforminę i gliburyd oraz jej zastosowanie do wytwarzania leku
IL172704A (en) Pharmaceuticals containing salinosporamide compound and use of this compound for the preparation of a cancer drug
HUP0402326A3 (en) Pharmaceutical composition for prevention of addiction in pain management
AP2004003087A0 (en) Oral dosage form for controlled drug release
EP1522324A4 (en) METHOD AND DEVICE FOR PRODUCING A MULTIPLE DOSER FOR A POWDERED MEDICAMENT
EP1694242A4 (en) PHARMACEUTICAL PREPARATIONS OF CAMPTOTHECINS AND METHOD FOR OBTAINING THEM
IL157707A0 (en) Composition and method for treatment or prevention of oral cavity disorders by local forms of drug delivery

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)